Renal surgery following HIF-2α antagonist therapy: Surgical indications, outcomes and growth kinetics. [PDF]
Nethala D +20 more
europepmc +1 more source
A Sustainable Spectrofluorimetric Quenching Approach for Determination of Pentoxifylline or Donepezil HCl via Complexation With Erythrosine B: Application to Tablets and Human Plasma. [PDF]
El Wahab MMA +3 more
europepmc +1 more source
Synthesis and biological evaluation, network pharmacology, and molecular docking of 2-benzylidene-1-indanone derivatives as antitumor agents. [PDF]
Liao X +4 more
europepmc +1 more source
Effects of chemical and biological warfare agent decontaminants on trace survival: Impact on fingermarks deposited on paper. [PDF]
Radgen-Morvant I +3 more
europepmc +1 more source
Preparation and in vitro Evaluation of Rasagiline Mesylate Hybrid Nanoparticles. [PDF]
Mahde BW, Abbas Hussein A, Sahib AS.
europepmc +1 more source
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. [PDF]
Gold R +12 more
europepmc +1 more source
Transdermal Microneedle-Mediated Delivery of Rasagiline Nanoparticles. [PDF]
Mahde BW +3 more
europepmc +1 more source
Long-Term Ozanimod Therapy in Patients With Moderately Active Ulcerative Colitis After Failure of 5-Aminosalicylic Acid. [PDF]
Yarur A +14 more
europepmc +1 more source
Disease progression trajectory curves to estimate saved time in Alzheimer's disease trials. [PDF]
Shan G, Zhang Y, Tang Z, Wang G, Wu SS.
europepmc +1 more source
A real-world data analysis of Ozanimod in the FDA Adverse Event Reporting System (FAERS) database. [PDF]
Tang Q +6 more
europepmc +1 more source

